Treatment of testicular cancer.
D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D004407:Dysgerminoma / Q000175:diagnosis / Q000532:radiotherapy / Q000628:therapy; D006689:Hodgkin Disease / Q000473:pathology; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000473:pathology; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D013724:Teratoma / Q000175:diagnosis / Q000532:radiotherapy / Q000628:therapy; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D014481:United States
D000277:Adjuvants, Pharmaceutic